Maridose has been licensed by the U.S Drug Enforcement Administration and Department of Justice for the bulk manufacture of cannabis to supply marijuana, MJ extracts (including isolated chemical constituents) and THC to researchers.
Marijuana legalization advocates have had mixed success so far this year in statehouses across the country.
They’ve scored legislative victories in Rhode Island, Mississippi and Maryland, laying the groundwork for hundreds of millions of dollars in combined sales for recreational and medical cannabis companies in those states.
Mississippi medical cannabis regulators opened the licensing application process last week for growers, processors, testing facilities and transporters, but it could be year-end before sales start.
Nearly four dozen Mississippi municipalities and counties have so far opted out of the state’s new medical marijuana program, with the deadline for doing so emerging in a few days.
The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida company with “conditional” approval from the U.S. Drug Enforcement Administration to grow marijuana for research purposes, applied to list on the Nasdaq stock exchange.
But the move also highlights the lofty – some say unrealistic – financial ambitions of such companies.
Mississippi signed a five-year agreement in which Texas-based Tyler Technologies will provide a platform to help state regulators process medical cannabis business applications and assorted registrations.
Florida-based seed-to-sale traceability company Metrc signed a contract to provide track-and-trace services to Mississippi’s medical marijuana program.
